Annual ROE:
-95.21%+32.43%(+25.41%)Summary
- As of today, OCUL annual return on equity is -95.21%, with the most recent change of +32.43% (+25.41%) on December 31, 2024.
- During the last 3 years, OCUL annual ROE has fallen by -87.22% (-1091.61%).
- OCUL annual ROE is now -1091.61% below its all-time high of -7.99%, reached on December 31, 2021.
Performance
OCUL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-83.37%-16.34%(-24.38%)Summary
- As of today, OCUL quarterly return on equity is -83.37%, with the most recent change of -16.34% (-24.38%) on September 30, 2025.
- Over the past year, OCUL quarterly ROE has dropped by -12.88% (-18.27%).
- OCUL quarterly ROE is now -102.84% below its all-time high of 2939.06%, reached on September 30, 2020.
Performance
OCUL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
OCUL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +25.4% | -18.3% |
| 3Y3 Years | -1091.6% | -3.2% |
| 5Y5 Years | - | -102.8% |
OCUL ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -1091.6% | +25.4% | -48.7% | +74.6% |
| 5Y | 5-Year | -1091.6% | +53.5% | -102.8% | +93.3% |
| All-Time | All-Time | -1091.6% | +53.5% | -102.8% | +98.3% |
OCUL ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -83.37%(-24.4%) |
| Jun 2025 | - | -67.03%(-19.6%) |
| Mar 2025 | - | -56.05%(+10.5%) |
| Dec 2024 | -95.21%(+25.4%) | -62.66%(+11.1%) |
| Sep 2024 | - | -70.49%(+9.5%) |
| Jun 2024 | - | -77.93%(+29.7%) |
| Mar 2024 | - | -110.88%(+59.6%) |
| Dec 2023 | -127.64%(-10.8%) | -274.31%(+16.3%) |
| Sep 2023 | - | -327.88%(-15.8%) |
| Jun 2023 | - | -283.16%(-51.1%) |
| Mar 2023 | - | -187.44%(-66.3%) |
| Dec 2022 | -115.16%(-1341.3%) | -112.69%(-39.4%) |
| Sep 2022 | - | -80.82%(-99.5%) |
| Jun 2022 | - | -40.51%(-52.8%) |
| Mar 2022 | - | -26.52%(-236.1%) |
| Dec 2021 | -7.99%(+96.1%) | -7.89%(+94.2%) |
| Sep 2021 | - | -136.73%(+36.0%) |
| Jun 2021 | - | -213.55%(+51.1%) |
| Mar 2021 | - | -436.50%(+64.6%) |
| Dec 2020 | -204.53% | -1234.74%(-142.0%) |
| Sep 2020 | - | 2939.06%(+160.6%) |
| Jun 2020 | - | -4846.19%(-230.2%) |
| Mar 2020 | - | -1467.75%(-163.2%) |
| Dec 2019 | - | -557.58%(-81.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -307.09%(-33.7%) |
| Jun 2019 | - | -229.73%(-46.5%) |
| Mar 2019 | - | -156.81%(-5.9%) |
| Dec 2018 | -193.41%(-19.2%) | -148.13%(-7.7%) |
| Sep 2018 | - | -137.48%(-0.2%) |
| Jun 2018 | - | -137.16%(-0.2%) |
| Mar 2018 | - | -136.95%(+2.3%) |
| Dec 2017 | -162.21%(-156.9%) | -140.23%(-16.5%) |
| Sep 2017 | - | -120.36%(-25.0%) |
| Jun 2017 | - | -96.29%(-26.9%) |
| Mar 2017 | - | -75.85%(-20.3%) |
| Dec 2016 | -63.14%(-17.8%) | -63.05%(-19.0%) |
| Sep 2016 | - | -52.97%(-6.8%) |
| Jun 2016 | - | -49.59%(+0.9%) |
| Mar 2016 | - | -50.04%(-2.8%) |
| Dec 2015 | -53.61%(+31.2%) | -48.68%(-0.9%) |
| Sep 2015 | - | -48.23%(+14.7%) |
| Jun 2015 | - | -56.53%(+25.7%) |
| Mar 2015 | - | -76.08%(+7.1%) |
| Dec 2014 | -77.88%(+0.5%) | -81.90%(+6.8%) |
| Sep 2014 | - | -87.87%(-195.7%) |
| Jun 2014 | - | 91.86%(+121.3%) |
| Mar 2014 | - | 41.51%(+291.6%) |
| Dec 2013 | -78.30%(-6.5%) | 10.60% |
| Dec 2012 | -73.54% | - |
FAQ
- What is Ocular Therapeutix, Inc. annual return on equity?
- What is the all-time high annual ROE for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. annual ROE year-on-year change?
- What is Ocular Therapeutix, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. quarterly ROE year-on-year change?
What is Ocular Therapeutix, Inc. annual return on equity?
The current annual ROE of OCUL is -95.21%
What is the all-time high annual ROE for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high annual return on equity is -7.99%
What is Ocular Therapeutix, Inc. annual ROE year-on-year change?
Over the past year, OCUL annual return on equity has changed by +32.43% (+25.41%)
What is Ocular Therapeutix, Inc. quarterly return on equity?
The current quarterly ROE of OCUL is -83.37%
What is the all-time high quarterly ROE for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high quarterly return on equity is 2939.06%
What is Ocular Therapeutix, Inc. quarterly ROE year-on-year change?
Over the past year, OCUL quarterly return on equity has changed by -12.88% (-18.27%)